Pharmacokinetics of Ertapenem in Patients With Varying Degrees of Renal Insufficiency and in Patients on Hemodialysis
- 1 October 2006
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 46 (10) , 1128-1138
Abstract
Ertapenem is a parenteral β‐lactam carbapenem antibiotic. This open‐label study examined the pharmacokinetics of single 1‐g intravenous doses of ertapenem, administered over 30 minutes, in patients with mild, moderate, and advanced renal insufficiency (RI) and in patients with end‐stage renal disease (ESRD) requiring hemodialysis. Pharmacokinetics were compared with historical controls pooled across healthy young and elderly subjects. Area under the concentration‐time curve from time zero to infinity increased 7% in mild, 53% in moderate, 158% in advanced RI, and 192% in ESRD; end of infusion concentration changed minimally; half‐life was 4.5 hours in the historical control group and 4.4, 6.1, 10.6, and 14.1 hours in mild RI, moderate RI, advanced RI, and ESRD, respectively. Hemodialysis cleared ∼30% of the dose. The recommended dose in mild to moderate RI and after hemodialysis is unchanged at 1 g daily; and in advanced RI and ESRD is reduced to 0.5 g daily. If the daily dose is given 6 hours prior to hemodialysis, a supplementary 150‐mg dose (30% of the daily dose) is recommended postdialysis.Keywords
This publication has 14 references indexed in Scilit:
- Pharmacokinetics and pharmacodynamics of ertapenem: an overview for cliniciansJournal of Antimicrobial Chemotherapy, 2004
- Pharmacokinetics of Total and Unbound Ertapenem in Healthy Elderly SubjectsAntimicrobial Agents and Chemotherapy, 2004
- Ertapenem Versus Piperacillin/Tazobactam in the Treatment of Complicated Intraabdominal InfectionsAnnals of Surgery, 2003
- A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumoniaClinical Therapeutics, 2002
- Pharmacokinetics of Ertapenem in Healthy Young VolunteersAntimicrobial Agents and Chemotherapy, 2002
- Ertapenem versus Ceftriaxone Followed by Appropriate Oral Therapy for Treatment of Complicated Urinary Tract Infections in Adults: Results of a Prospective, Randomized, Double-Blind Multicenter StudyAntimicrobial Agents and Chemotherapy, 2002
- Ertapenem Once Daily Versus Piperacillin‐Tazobactam 4 Times per Day for Treatment of Complicated Skin and Skin‐Structure Infections in Adults: Results of a Prospective, Randomized, Double‐Blind Multicenter StudyClinical Infectious Diseases, 2002
- A Study Evaluating the Efficacy, Safety, and Tolerability of Ertapenem versus Ceftriaxone for the Treatment of Community‐Acquired Pneumonia in AdultsClinical Infectious Diseases, 2002
- In Vivo Activity and Pharmacokinetic Evaluation of a Novel Long-Acting Carbapenem Antibiotic, MK-826 (L-749,345)Antimicrobial Agents and Chemotherapy, 1998
- Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogensAntimicrobial Agents and Chemotherapy, 1997